PROBLEMS IN CLINICAL RESISTANCE.

PROBLEMS IN CLINICAL RESISTANCE. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

PROBLEMS IN CLINICAL RESISTANCE. Abstract Text:

PROBLEMS IN CLINICAL RESISTANCE. Publishing Authors By Initials

For similar therapeutics: drug therapy research abstracts see: therapeutics: drug therapy research

PUBMED ID PMID:

MEDLINE DATE:

PROBLEMS IN CLINICAL RESISTANCE. Journal Published:

PUBLICATION TYPE: Review

Journal: Proceedings. Canadian Cancer Conference

VOLUME: 5

Page Numbers: 449-53

Journal Abbreviation:

ISSN: 0068-8436

DAY: 15

MONTH: 04

YEAR: 1963

PROBLEMS IN CLINICAL RESISTANCE. Information

Number of References: 0

LANGUAGE: eng

NlmUniqueID: 23710060

PROBLEMS IN CLINICAL RESISTANCE. Keywords Mesh Terms:

KEYWORDS: Drug Therapy

MESH TERMS:

Chemical & Substance for Abstract: PROBLEMS IN CLINICAL RESISTANCE. Information

Substance Name: Antineoplastic Agents

Registry Number: 0

Grant and Affiliation Information for PROBLEMS IN CLINICAL RESISTANCE.

AFFILIATION:

Country: CANADA

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Proc Can Cancer Conf

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

PROBLEMS IN CLINICAL RESISTANCE Related Publications

• A summary of the clinical status of asparaginase.
• Analysis of long-term survival in acute leukemia and Burkitt's tumor--effects to be expected from intensive therapy and asparaginase.
• Chemotherapy of blood dyscrasias.
• Clinical experience with L-asparaginase.
• Clinical experiences with actinomycins D, KS2, and F1 (KS4).
• Clinical observations on the effects of streptonigrin in patients with neoplastic disease.
• Clinical trial of 5-hydroxypicolinaldehyde thiosemicarbazone (5-HP; NSC-107392), with special reference to its iron-chelating properties.
• Comparative results obtained in the treatment of acute leukemia.
• Continuous intraarterial methotrexate with simultaneous, intermittent, intramuscular citrovorum factor herapy in carcinoma of the cervix.
• Heterophile antibodies and antigens in neoplastic diseases.
• Malignant lymphoma involving the jaw in African children: treatment with 2-chloro-4',4'-di-2-imidazolin-2-ylterephthalanilide dihydrochloride.
• Oxygen saturation of sternal marrow blood with special reference to pathogenesis of polycythemia vera.
• PHYSIOLOGICAL DISPOSITION AND BIOCHEMICAL REACTIONS OF THE 14C-4',4''-BIS(2-IMIDAZOLIN-2-YL) 2-CHLOROTEREPHTHALANILIDE DIHYDROCHLORIDE IN MICE AND RATS IN VIVO AND IN VITRO.
• PROBLEMS IN CLINICAL RESISTANCE.
• Predicting systems for antitumor activity--purine antagonists.
• Proceedings: The future of cancer chemotherapy.
• Recent advances and perspectives in the chemotherapy of acute leukemia.
• Studies on the chemotherapy of leukemia; the effect of 4-amino-pteroylglutamic acid and 4-amino-N10-methyl-pteroylglutamic acid on transplanted mouse leukemia.
• The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine).
• The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report.
• The newer nitrogen mustards in the treatment of leukemia.